Fatal hyperhemolytic delayed transfusion reaction in sickle cell disease: A case report and literature review (Q37786399)

23 August 2017

title

Fatal hyperhemolytic delayed transfusion reaction in sickle cell disease: a case report and literature review (English)

1 reference

23 August 2017

Fatal hyperhemolytic delayed transfusion reaction in sickle cell disease: A case report and literature review (English)

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

9 July 2024

0 references

1

Amr El-Husseini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20825863

9 July 2024

author name string

Alaa Sabry

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0735675710000343?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

https://api.elsevier.com/content/article/PII:S0735675710000343?httpAccept=text/plain

9 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

The American Journal of Emergency Medicine

9 July 2024

published in

1 reference

23 August 2017

volume

28

1 reference

23 August 2017

issue

9

1 reference

23 August 2017

page(s)

1062.e5-8

1 reference

Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Principles and problems of transfusion in sickle cell disease

9 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Severe reactions associated with transfusion of patients with sickle cell disease

9 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease

9 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Bystander immune cytolysis

9 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia

9 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction

9 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells

9 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Hyperhemolytic transfusion reaction in sickle cell disease

9 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

9 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Delayed haemolytic transfusion reaction and hyperhaemolysis complicating peri-operative blood transfusion in sickle cell disease

9 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease

9 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Hyperhemolysis syndrome: a relative contraindication for transfusion

9 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review

9 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges

9 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.

9 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

9 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Current issues in blood transfusion for sickle cell disease

9 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

New Views of Sickle Cell Disease Pathophysiology and Treatment.

9 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Hypercoagulability in sickle cell disease: a curious paradox

9 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state

9 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

An evidence-based approach to the treatment of adults with sickle cell disease

9 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.AJEM.2010.01.032

9 July 2024

Identifiers

1 reference

23 August 2017

1 reference